Wednesday, August 11, 2010

Levaquin

Treating life-threatening illnesses with antibiotics has been a common practice since the discovery of penicillin. All too frequently wounded soldiers and patients would die from infected wounds until antibiotics joined the physician's arsenal. Since that time, bacteria have evolved, making them more resistant to traditional antibiotics.

Drug companies are continually manufacturing powerful antibiotics to defeat antibiotic-resistant bacteria. Unfortunately, when used improperly these antibiotics may also be considered dangerous drugs. Levaquin, made by Ortho-McNeil, a subsidiary of Johnson and Johnson, is one of the most popular antibiotics on the market today.

Levaquin Treats Bacterial Infections

In the past, many physicians treated anything that looked like it might be an infection with a course of penicillin or other antibiotic, regardless of whether it was a bacterial infection or not. Antibiotics do not work against viral infections. It was thought that it was better to be safe than sorry, but the more frequently antibiotics were used, the faster bacteria adapted to it.

Levaquin is approved by the FDA to treat the following common infections:

• Respiratory tract infections
• Genitourinary tract infections
• Bacterial skin infections

Man-made antibiotics like Levaquin should only be used when the infection is certain to be bacterial. This will ensure that the bacteria will be killed by the Levaquin treatment but minimize the potentially dangerous side effects that occur with Levaquin.

If you or a loved one has suffered ill effects of improperly-prescribed Levaquin, please contact the pharmaceutical litigation attorneys at Schlichter, Bogard & Denton, serving clients nationwide, to schedule an initial consultation.

posted by Lynn at 8:00 AM

Archives

Drug Injury and Recall Blog

Dangerous and Defective Pharmaceutical Products

1.800.873.5297 Email Us

Welcome to the dangerous prescription drugs website of Schlichter, Bogard & Denton,
please upgrade your Flash Plugin and enable JavaScript to see our pharmaceutical injury video.